BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2434508)

  • 1. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (IV). Effects of heparin and its analogues.
    Sato H; Nakajima A; Shimohira T
    Thromb Res; 1985 Sep; 39(5):549-57. PubMed ID: 4082100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin inhibitory activity of heparin cofactor II depends on the molecular weight and sulfate amount of dextran sulfate.
    Yamagishi R; Niwa M; Sakuragawa N
    Thromb Res; 1986 Nov; 44(3):347-54. PubMed ID: 2432675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (III) Effects of competitive inhibitors.
    Sato H; Nakajima A
    Thromb Res; 1985 Jan; 37(2):327-35. PubMed ID: 3975875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex.
    Hogg PJ; Jackson CM
    J Biol Chem; 1990 Jan; 265(1):241-7. PubMed ID: 2294104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of anticoagulant activity of a novel heparinoid sulfated glucoside-bearing polymer.
    Sakamoto N; Kishida A; Maruyama I; Akashi M
    J Biomater Sci Polym Ed; 1997; 8(7):545-53. PubMed ID: 9195333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choices among the possible reaction routes catalyzed by thrombin.
    Machovich R
    Ann N Y Acad Sci; 1986; 485():170-83. PubMed ID: 2436523
    [No Abstract]   [Full Text] [Related]  

  • 12. Dependence of the rate of thrombin/antithrombin III reaction upon the turnover rate of a catalytic amount of heparin.
    Oshima G
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2155-9. PubMed ID: 2598315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III.
    Gan ZR; Li Y; Chen Z; Lewis SD; Shafer JA
    J Biol Chem; 1994 Jan; 269(2):1301-5. PubMed ID: 8288594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dextran sulphates on thrombin activity.
    Suzuki K; Hashimoto S
    J Clin Pathol; 1979 May; 32(5):439-44. PubMed ID: 469001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NaC1 on inactivation of bovine thrombin by antithrombin III in the presence of low affinity-heparin or dextran sulfate.
    Oshima G; Nagasawa K
    Thromb Res; 1986 Feb; 41(3):361-72. PubMed ID: 2422780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant activity of dextran derivatives.
    de Raucourt E; Mauray S; Chaubet F; Maiga-Revel O; Jozefowicz M; Fischer AM
    J Biomed Mater Res; 1998 Jul; 41(1):49-57. PubMed ID: 9641623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the sulfated lactobionic acid amide LW 10082 with thrombin and its endogenous inhibitors.
    Klauser RJ
    Thromb Res; 1991 Jun; 62(5):557-65. PubMed ID: 1896968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.